Sign In to Follow Application
View All Documents & Correspondence

A Composition Comprising Adenosine Triphosphate, And Gluconolactone And Uses Thereof

Abstract: The present disclosure provides a combination of adenosine triphosphate and gluconolactone for promoting wound healing at particular weight ratio combinations. Also provided are formulations comprising said composition, and patches for topical application to promote epithelial wound healing.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
02 November 2015
Publication Number
18/2017
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
lsmds@lakshmisri.com
Parent Application
Patent Number
Legal Status
Grant Date
2023-10-20
Renewal Date

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India

Inventors

1. KUMARI, Deva
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India
2. Y, Sree Gouri
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India
3. CHANDRASEKHARAN, Lakshmanan Chittur
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India
4. BANDYOPADHYAY, Balaji
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India

Specification

Claims:1. A composition comprising:
- adenosine triphosphate; and
- gluconolactone,
wherein adenosine triphosphate to gluconolactone w/w ratio in said composition is in the range of 2.5:1-40:1.
2. The composition as claimed in claim 1, wherein adenosine triphosphate to gluconolactone w/w ratio in said composition is 10:1.
3. The composition as claimed in claim 1, wherein adenosine triphosphate weight concentration in said composition is in the range of 0.05-0.2%, and gluconolactone weight concentration in said composition is in the range of 0.005-0.02%.
4. A method of preparing a composition as claimed in any of the claims 1-3.
5. A formulation comprising:
- adenosine triphosphate;
- gluconolactone; and
- suitable carriers, diluents, and excipients,
wherein adenosine triphosphate to gluconolactone w/w ratio in said formulation is in the range of 2.5:1-40:1.
6. The formulation as claimed in claim 5, wherein adenosine triphosphate to gluconolactone w/w ratio in said formulation is 10:1.
7. A method of preparing a formulation as claimed in any of the claims 5-6.
8. A method of promoting epithelial wound healing, said method comprising:
- obtaining a composition as claimed in any of the claims 1-3; and
- contacting said composition with site of epithelial wound,
wherein said method promotes epithelial wound healing.
9. A method of promoting epithelial wound healing, said method comprising:
- obtaining a formulation as claimed in any of the claims 5-6; and
- contacting said formulation with site of epithelial wound,
wherein said method promotes epithelial wound healing.
10. A patch for topical application for epithelial wound healing comprising a composition as claimed in any of the claims 1-3, further optionally comprising suitable carriers, diluents, and excipients.
11. A composition comprising a composition as claimed in any of the claims 1-3, or a formulation as claimed in any of the claims 5-6 for use in promoting epithelial wound healing.
, Description:As Attached

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 5931-CHE-2015-IntimationOfGrant20-10-2023.pdf 2023-10-20
1 Sequence listing [02-11-2015(online)].pdf 2015-11-02
2 5931-CHE-2015-PatentCertificate20-10-2023.pdf 2023-10-20
2 Form 5 [02-11-2015(online)].pdf 2015-11-02
3 Form 3 [02-11-2015(online)].pdf 2015-11-02
3 5931-CHE-2015-Written submissions and relevant documents [19-10-2023(online)].pdf 2023-10-19
4 Drawing [02-11-2015(online)].pdf 2015-11-02
4 5931-CHE-2015-FORM-26 [04-10-2023(online)].pdf 2023-10-04
5 Description(Complete) [02-11-2015(online)].pdf 2015-11-02
5 5931-CHE-2015-Correspondence to notify the Controller [03-10-2023(online)].pdf 2023-10-03
6 5931-CHE-2015-US(14)-HearingNotice-(HearingDate-05-10-2023).pdf 2023-09-05
6 5931-CHE-2015-Power of Attorney-050116.pdf 2016-06-16
7 5931-CHE-2015-Form 1-050116.pdf 2016-06-16
7 5931-CHE-2015-CLAIMS [04-11-2022(online)].pdf 2022-11-04
8 5931-CHE-2015-FER_SER_REPLY [04-11-2022(online)].pdf 2022-11-04
8 5931-CHE-2015-Correspondence-F1-PA-050116.pdf 2016-06-16
9 5931-CHE-2015-FORM 18 [27-09-2019(online)].pdf 2019-09-27
9 5931-CHE-2015-SEQUENCE LISTING [04-11-2022(online)].txt 2022-11-04
10 5931-CHE-2015-FER.pdf 2022-05-04
11 5931-CHE-2015-FORM 18 [27-09-2019(online)].pdf 2019-09-27
11 5931-CHE-2015-SEQUENCE LISTING [04-11-2022(online)].txt 2022-11-04
12 5931-CHE-2015-Correspondence-F1-PA-050116.pdf 2016-06-16
12 5931-CHE-2015-FER_SER_REPLY [04-11-2022(online)].pdf 2022-11-04
13 5931-CHE-2015-CLAIMS [04-11-2022(online)].pdf 2022-11-04
13 5931-CHE-2015-Form 1-050116.pdf 2016-06-16
14 5931-CHE-2015-Power of Attorney-050116.pdf 2016-06-16
14 5931-CHE-2015-US(14)-HearingNotice-(HearingDate-05-10-2023).pdf 2023-09-05
15 5931-CHE-2015-Correspondence to notify the Controller [03-10-2023(online)].pdf 2023-10-03
15 Description(Complete) [02-11-2015(online)].pdf 2015-11-02
16 5931-CHE-2015-FORM-26 [04-10-2023(online)].pdf 2023-10-04
16 Drawing [02-11-2015(online)].pdf 2015-11-02
17 5931-CHE-2015-Written submissions and relevant documents [19-10-2023(online)].pdf 2023-10-19
17 Form 3 [02-11-2015(online)].pdf 2015-11-02
18 5931-CHE-2015-PatentCertificate20-10-2023.pdf 2023-10-20
18 Form 5 [02-11-2015(online)].pdf 2015-11-02
19 5931-CHE-2015-IntimationOfGrant20-10-2023.pdf 2023-10-20

Search Strategy

1 SearchE_28-04-2022.pdf

ERegister / Renewals

3rd: 31 Oct 2023

From 02/11/2017 - To 02/11/2018

4th: 31 Oct 2023

From 02/11/2018 - To 02/11/2019

5th: 31 Oct 2023

From 02/11/2019 - To 02/11/2020

6th: 31 Oct 2023

From 02/11/2020 - To 02/11/2021

7th: 31 Oct 2023

From 02/11/2021 - To 02/11/2022

8th: 31 Oct 2023

From 02/11/2022 - To 02/11/2023

9th: 31 Oct 2023

From 02/11/2023 - To 02/11/2024

10th: 27 Mar 2024

From 02/11/2024 - To 02/11/2025

11th: 24 Oct 2025

From 02/11/2025 - To 02/11/2026